JAMA研究:约四分之一美国陆军现役男性晨间睾酮筛查值低于常用阈值
Low testosterone screening rates among US army personnel examined
JAMA发布的一项研究估计,约25.7%(约100,691人)的美国陆军现役男性晨间睾酮水平低于300 ng/dL这一常用筛查阈值。研究分析了479名来自五个陆军设施男性参与者的数据,使用264 ng/dL阈值时对应检出率约14.7%(约57,788人)。年长和BMI较高者低筛查结果更常见,但研究者强调单次低值不等于性腺功能减退诊断,需重复检测并结合临床评估。
Approximately 1 in 4 active-duty male U.S. Army personnel may have a morning testosterone measurement below a commonly used clinical threshold, according to new research from Pennington Biomedical Research Center published this week in JAMA. The findings provide estimates of low testosterone screening results across the active-duty Army population and offer insight into the potential implications of routine testosterone screening for military personnel.
The study, "Testosterone Screening Thresholds and Low Testosterone in Active-Duty US Service Members," analyzed data from 479 male participants in the Military Health and Nutrition Examination Study, a multisite assessment conducted at five U.S. Army installations between August 2024 and January 2026. Researchers estimated the prevalence of testosterone concentrations below two commonly used thresholds for identifying low testosterone: less than 300 nanograms per deciliter (ng/dL) and less than 264 ng/dL.
Using the 300 ng/dL threshold, researchers estimated that 25.7% of active-duty male Army personnel—approximately 100,691 individuals—would have a morning testosterone measurement below that level. Using the lower threshold of 264 ng/dL, the estimated prevalence was 14.7%, representing approximately 57,788 men.
"Pennington Biomedical has proudly collaborated with the U.S. military for more than 30 years to advance research that supports the health, performance and readiness of service members," said Dr. Jennifer Rood, senior vice chancellor and executive director of Pennington Biomedical. "Our participation in the Military Health and Nutrition Examination Study reflects this longstanding partnership and our shared commitment to understanding the factors that influence health across the military population. This research provides valuable evidence to help inform health monitoring and support the well-being of those who serve our country."
The findings come as a Department of War memorandum calls for annual testosterone screening for active-duty and reserve military personnel ages 30 and older, underscoring the importance of understanding how frequent screening may identify low testosterone measurements.
"Understanding the prevalence of low testosterone measurements in military personnel is important as screening practices evolve," said Dr. Claire E. Berryman, a former Pennington Biomedical researcher now at Purdue University and corresponding author of the study. "These findings help quantify how many service members may require follow-up testing and clinical evaluation after an initial screening."
Researchers also found that low testosterone measurements were more common among older men and men with higher body mass index (BMI). Among men younger than 30, an estimated 19.5% had testosterone concentrations below 300 ng/dL, compared with 32.8% of men ages 30 and older. Using the 264 ng/dL threshold, the corresponding estimates were 11.4% and 18.6%, respectively.
For the study, Dr. Stephen R. Hennigar, LSU Boyd Professor Dr. Steven Heymsfield, Dr. Asma S. Bukhari and Berryman collaborated with Dr. Harris R. Lieberman of the U.S. Army Research Institute of Environmental Medicine.
The researchers emphasized that a low screening measurement is not the same as a diagnosis of hypogonadism, a clinical condition involving testosterone deficiency. Testosterone concentrations can vary with age, time of day, obesity, illness and physical stress. Clinical guidelines recommend testing men who have signs or symptoms consistent with testosterone deficiency, and a low morning testosterone result generally requires confirmation through repeat testing and further clinical evaluation.
"This distinction is particularly important when interpreting population-level screening estimates," the researchers noted in the paper. A single low measurement may prompt additional evaluation, but it does not establish that an individual has a clinical condition requiring treatment.
The study's findings also highlight the importance of careful interpretation of screening results as military health systems evaluate approaches to monitoring the health and readiness of service members. The researchers noted that the study relied on a single testosterone measurement for each participant, and that differences in laboratory assays may affect classification near clinical thresholds.
Publication details
Stephen R. Hennigar et al., Testosterone Screening Thresholds in Active-Duty US Male Service Members, JAMA (2026). DOI: 10.1001/jama.2026.19794
Journal information: Journal of the American Medical Association
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Low testosterone screening rates among US army personnel examined (2026, October 15) retrieved 15 October 2026 from https://medicalxpress.com/news/2026-10-testosterone-screening-army-personnel.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com